Biolargo, Inc.
BLGO· OTC
Filed Aug 15, 2011 · 10-Q · 46 days after period end · 0001437749-11-006047
| Metric | Q2 2011 | Q2 2010 |
|---|---|---|
| Revenue | $12.22K | $80.79K |
| Net Income | -$892.07K | -$1.29M |
| EPS Diluted | -$0.02 | -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biolargo, Inc. · CIK 880242 · Engraved from SEC EDGAR
ended Jun 30, 2011 · filed Aug 15, 2011 · 46 d after period end